BR9810163A - Compostos ou suas composições - Google Patents

Compostos ou suas composições

Info

Publication number
BR9810163A
BR9810163A BR9810163-3A BR9810163A BR9810163A BR 9810163 A BR9810163 A BR 9810163A BR 9810163 A BR9810163 A BR 9810163A BR 9810163 A BR9810163 A BR 9810163A
Authority
BR
Brazil
Prior art keywords
compounds
compositions
general formula
connection bridge
pharmaceutical compositions
Prior art date
Application number
BR9810163-3A
Other languages
English (en)
Other versions
BR9810163B1 (pt
Inventor
Piero Del Soldato
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of BR9810163A publication Critical patent/BR9810163A/pt
Publication of BR9810163B1 publication Critical patent/BR9810163B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

"COMPOSTOS OU SUAS COMPOSIçõES" Os compostos da fórmula geral A-X~ 1~-NO~ 2~ ou suas composições farmacêuticas, em que A contém um resíduo de prostaglandina, X~ 1~ é uma ponte de conexão bivalente.
BRPI9810163-3A 1997-06-19 1998-06-17 compostos liberadores de àxido nÍtricos. BR9810163B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001440A IT1292377B1 (it) 1997-06-19 1997-06-19 Composizioni farmaceutiche a base di prostaglandine
PCT/EP1998/003645 WO1998058910A1 (en) 1997-06-19 1998-06-17 Prostaglandin pharmaceutical compositions

Publications (2)

Publication Number Publication Date
BR9810163A true BR9810163A (pt) 2000-08-08
BR9810163B1 BR9810163B1 (pt) 2009-01-13

Family

ID=11377397

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9810163-3A BR9810163B1 (pt) 1997-06-19 1998-06-17 compostos liberadores de àxido nÍtricos.

Country Status (19)

Country Link
US (1) US6211233B1 (pt)
EP (1) EP0989972B1 (pt)
JP (1) JP4394170B2 (pt)
KR (1) KR20010013625A (pt)
CN (1) CN1260778A (pt)
AT (1) ATE225771T1 (pt)
AU (1) AU740683B2 (pt)
BR (1) BR9810163B1 (pt)
CA (1) CA2292836C (pt)
DE (1) DE69808619T2 (pt)
DK (1) DK0989972T3 (pt)
ES (1) ES2185188T3 (pt)
HU (1) HUP0004071A3 (pt)
IL (1) IL132690A (pt)
IT (1) IT1292377B1 (pt)
PT (1) PT989972E (pt)
RU (1) RU2000100807A (pt)
SI (1) SI0989972T1 (pt)
WO (1) WO1998058910A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
WO2002060387A2 (en) * 2001-01-30 2002-08-08 Pharmaceutical Research Corporation Use of prostaglandin analogs for treatment of cardiac conditions
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7011854B2 (en) * 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP1562975A2 (en) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
NZ548271A (en) * 2004-01-05 2010-01-29 Nicox Sa Prostaglandin nitrooxyderivatives
WO2007000641A2 (en) * 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
EP1917239A1 (en) * 2005-06-29 2008-05-07 Pfizer, Inc. Fluoroprostaglandins nitroderivatives
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
CA2647859C (en) 2006-03-29 2016-01-05 Nitromed, Inc. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
US8041859B2 (en) * 2007-11-05 2011-10-18 Honywell International Inc. Apparatus and method for connectivity in networks capable of non-disruptively disconnecting peripheral devices
WO2012145520A2 (en) 2011-04-19 2012-10-26 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
WO2013013179A1 (en) 2011-07-21 2013-01-24 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
WO2014111957A1 (en) 2013-01-21 2014-07-24 Apparao Satyam Nitric oxide releasing prodrugs of therapeutic agents
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3371199D1 (en) * 1982-08-24 1987-06-04 Teijin Ltd Novel 6-nitroprostaglandin derivatives, process for production thereof, and use thereof
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
IT1243367B (it) 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en) * 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
KR100387359B1 (ko) 1994-05-10 2003-08-27 니콕스 에스. 에이. 항-염증성,비알러지성및항-혈전성을가지는니트로화합물들과그들의조성물들
US5625083A (en) * 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins

Also Published As

Publication number Publication date
PT989972E (pt) 2003-02-28
ES2185188T3 (es) 2003-04-16
EP0989972B1 (en) 2002-10-09
DE69808619T2 (de) 2003-06-12
CA2292836A1 (en) 1998-12-30
HUP0004071A2 (hu) 2001-04-28
WO1998058910A1 (en) 1998-12-30
RU2000100807A (ru) 2002-02-27
US6211233B1 (en) 2001-04-03
EP0989972A1 (en) 2000-04-05
HUP0004071A3 (en) 2002-12-28
ITMI971440A1 (it) 1998-12-19
SI0989972T1 (en) 2003-04-30
CA2292836C (en) 2010-03-02
ITMI971440A0 (pt) 1997-06-19
JP4394170B2 (ja) 2010-01-06
DE69808619D1 (de) 2002-11-14
IT1292377B1 (it) 1999-02-08
AU8438698A (en) 1999-01-04
JP2002506440A (ja) 2002-02-26
AU740683B2 (en) 2001-11-08
IL132690A0 (en) 2001-03-19
DK0989972T3 (da) 2003-02-10
BR9810163B1 (pt) 2009-01-13
ATE225771T1 (de) 2002-10-15
IL132690A (en) 2004-06-01
KR20010013625A (ko) 2001-02-26
CN1260778A (zh) 2000-07-19

Similar Documents

Publication Publication Date Title
BR9810163A (pt) Compostos ou suas composições
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
DK0941218T3 (da) Antithrombotiske organiske nitrater
BR0011863A (pt) Conjugados de fitosterol ou fitostanol com ácido ascórbico e uso destes no tratamento ou prevenção de doença cardiovascular
BR9911771A (pt) Compostos cìclicos substituìdos, um processo para sua preparação e composições farmacêuticas que contêm os mesmos
ATE306261T1 (de) Antithrombosemittel
BR9814679A (pt) acido ciclopentano heptanenóico, derivados de 2-heteroarilalquenila como agentes terapêuticos
BR9813848A (pt) Composto heterocìclico fundido substituìdo, uso do mesmo, e, composição farmacêutica.
TR199501329A2 (tr) Protez dis sabitlestirme terkipleri.
DK0750631T3 (da) Mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[c]azepin-3-ondisulfidderivater som enkephalinase- og ACE-inhibitorer
FR12C0005I2 (fr) Utilisation d'une composition estroprogestative en tant que contraceptif oral
BR9811914A (pt) Composição sólida para reduzir a erosão dos dentes
BR9808140A (pt) Formulação unitária
BRPI0413976A (pt) análogos da prostaglandina ciclohexila como agonistas do receptor ep4
ES551274A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
NO302519B1 (no) Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
BR0012478A (pt) Derivados de aminotiazóis, sua preparação e composição farmacêuticas contendo os mesmos
NO995590D0 (no) 20-Aryl-5<alfa>-pregnan-derivater
BR9812780A (pt) 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio
BR0109022A (pt) Método de preparação de citalopram e sua composição farmacêutica
NO20022977L (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
BR9904951A (pt) Compostos cìclicos tendo uma cadeia cicloalquileno, processo para sua preparação e composições farmacêuticas contendo os mesmos
BR9907426A (pt) Tetrahidronaftalenos
BR9912885A (pt) Derivado de 3-azabiciclo-[3.2.0]- heptano n-substituìdo
BR9910401A (pt) Nova formulação contendo paroxetina

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: NICOX S.A. (FR)

Free format text: ANOTADAS AS ALTERACOES DE SEDE CONFORME SOLICITADO NA PETICAO NO 020050046572/RJ DE 06/06/2005.

B25G Requested change of headquarter approved

Owner name: NICOX S.A. (FR)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070016104/RJ DE 07/02/2007.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/01/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 13.01.2019